Advanced Wound Care and Regenerative Medicine Access and Reform Act

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

• Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

• Energy and Commerce Committee
  House of Representatives
• Ways and Means Committee
  House of Representatives

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

• NATIONAL ASSOCIATION OF ACCOUNTABLE CARE ORGANIZATIONS
  for NATIONAL ASSOCIATION OF ACCOUNTABLE CARE ORGANIZATIONS · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
• THE MCMANUS GROUP
  for VENTURE MEDICAL · Montana · 3rd Quarter 2026 (July 1 - Sep 30)
• THE MCMANUS GROUP
  for BIOWOUND SOLUTIONS · Nevada · 3rd Quarter 2026 (July 1 - Sep 30)
• THE MCMANUS GROUP
  for ACESSO BIOLOGICS · Nevada · 3rd Quarter 2026 (July 1 - Sep 30)
• ORGANOGENESIS INC.
  for ORGANOGENESIS INC. · Massachusetts · 3rd Quarter 2026 (July 1 - Sep 30)
• THE PICARD GROUP, LLC
  for HARBINGER MEDICAL GROUP LLC DBA TIDES MEDICAL · Louisiana · 3rd Quarter 2026 (July 1 - Sep 30)

Bodies those filers lobbied

• HOUSE OF REPRESENTATIVES
  35 filings
• SENATE
  35 filings
• Centers For Medicare and Medicaid Services (CMS)
  19 filings
• Health & Human Services, Dept of (HHS)
  11 filings
• Office of Management & Budget (OMB)
  3 filings
• White House Office
  2 filings

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.